Source BioScience

Source Genomics, part of the Source BioScience group, delivers genomic and multi-omic services designed to accelerate innovation with high-quality, reliable solutions. Leveraging over two decades of expertise in genomic sequencing and the latest technological advancements, the company provides a comprehensive range of services to support early-stage R&D, translational research, clinical trials, and clinical diagnostics. These services cover advanced molecular testing, assay development, biomarker validation, and fully accredited laboratory operations, enabling a seamless transition from discovery to clinical application and accelerating progress along the research-to-diagnostics pipeline. Source Genomics also provides specialist clinical diagnostic services across oncology, virology, and hereditary conditions, alongside validation studies for clinical research. These integrated services strengthen an end-to-end laboratory offering, combining biomarker-driven genomic testing with established clinical histopathology expertise to deliver a comprehensive, high-quality solution.